Women’s health therapeutics market to be valued at $61.6b by 2032

Thanks to an increased focus on reproductive health, menopause, and breast cancer treatment.

The global women’s health therapeutics market is projected to reach $61.6b by 2032 at a compound annual growth rate of 4.05%, said SNS Insider.

The sector’s expansion is attributed to an increased focus on reproductive health, menopause, and breast cancer treatment.

Moreover, conditions such as endometriosis, uterine fibroids, and osteoporosis are seeing heightened demand for specialised care.

“As women increasingly learn about their health care, they are receiving highly significant treatment options that look at areas that have been long neglected,” the report said.

Meanwhile, the demand for innovative solutions is rising due to technological advancements and personalised medicine. This trend is supported by collaborations between healthcare providers and advocacy groups, working to offer more care options.